Trial Profile
A multicentre, randomized, open label, parallel group pilot study comparing efficacy and safety of sufentanil transdermal delivery system (TDS) to oral sustained release morphine sulphate in patients with chronic cancer pain.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Morphine (Primary) ; Sufentanil (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors hameln rds
- 09 Mar 2017 New trial record